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Purpose: Continuous cardiac monitoring in a stroke unit (SU) may improve detec-
tion of atrial fibrillation (AF), and SU care may improve the rate of anticoagulation 
by better adherence to a standardized treatment protocol in patients with AF. We in-
vestigated the effects of the SU on the detection of AF and the rate of warfarin ther-
apy in patients with AF. Materials and Methods: Acute stroke patients who had 
been admitted before or after the opening of the SU were included in our study. SU 
patients were monitored continuously with electrocardiography. Rates of AF and 
warfarin therapy were compared between patients admitted to the SU (SU group) 
and those admitted to the general ward (GW) prior to the opening of the SU (GW 
group). Results: Total 951 patients had been admitted to the GW prior to the open-
ing of the SU (from January 2000 to November 2002), and 2349 patients to the SU 
(from January 2003 to December 2008). AF was found in 149 patients (15.7%) in 
the GW group and in 487 (20.7%) in the SU group. Most of AF detected during ad-
mission was paroxysmal AF (84.8%). The frequency of newly detected AF was 
higher in the SU group than the GW group (2.5% vs. 0.7%, p=0.001). The rate of 
anticoagulation consideration was also higher in the SU group. Conclusion: SU 
care improved the detection of AF and the rate of anticoagulation consideration in 
acute stroke patients. Our findings support the benefits of continuous cardiac moni-
toring in the SU for stroke patients.
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INTRODUCTION
Organized stroke care in a stroke unit (SU) constitutes a standardized protocol for 
acute evaluation and management by a coordinated, multidisciplinary stroke team.1 
The essential part of the intensive SU model includes monitoring of physical and 
neurological status,2 and care in the SU is known to improve the outcome of stroke 
patients.3 However, there are several issues that are not clearly resolved yet. First, 
it is still unknown why care in the SU improves the outcomes of stroke patients.4 
Second, there are controversies regarding the necessity of continuous cardiac mon-
itoring in the SU.5,6  
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stay, a standard 12-lead ECG was performed immediately 
when AF was suspected based on ECG monitoring by con-
tinuous inspection of trained nurses or physicians. In the 
GW, follow-up standard ECG was also performed when ar-
rhythmia was detected or suspected during admission. AF 
was classified as paroxysmal if episodes terminated sponta-
neously in less than seven days. All other types of AF were 
classified as persistent/permanent. 
The treatment protocol was the same both before and af-
ter the opening of the SU. The standard treatment protocol 
in acute ischemic stroke patients with AF includes oral anti-
coagulation. Therefore, all patients with AF who were en-
rolled in our study should have been treated with warfarin, 
except patients with contraindications for anticoagulation. 
Whether the patient was prescribed warfarin at discharge 
was reviewed. If the medical records illustrated reasons of 
why the patient should not receive anticoagulants, the pa-
tient was regarded as being considered for anticoagulation. 
We investigated both rates for anticoagulation rate and anti-
coagulation consideration.
Analysis 
The frequencies of AF which were documented at admis-
sion and during hospitalization were compared between pa-
tients admitted to the SU (SU group) and those admitted to 
the GW prior to the opening of the SU (GW group). The an-
ticoagulation rates of AF were also compared between the 
SU and GW groups. The SPSS for Windows (version 18.0, 
SPSS Inc., Chicago, IL, USA) was used for statistical analy-
ses. The independent samples t-test and the Pearson χ2 test 
were used for comparisons between the GW group and the 
SU group. Significance was set at p<0.05. 
RESULTS
 
General characteristics
Prior to the opening of the SU (from January 2000 to No-
vember 2002), 951 patients with acute cerebral infarction 
or TIA were admitted to the neurology department, within 
7 days after symptom onset. After the opening of the SU 
(from January 2003 to December 2008), 3016 acute stroke 
patients were admitted within 7 days after symptoms onset. 
Of these 3016 patients, 2349 (77.9%) stayed in the SU dur-
ing their hospitalization. The remaining patients were not 
admitted to the SU due to unavailability of bed in the SU or 
presentation to the hospital later than 3 days after symptom 
Stroke patients with atrial fibrillation (AF) have a higher 
stroke recurrence rate than those without AF. This is as-
sumed to be due to a high embolic risk, a low detection rate 
of paroxysmal AF, and/or inadequate anticoagulation with 
vitamin-K antagonists.7 Continuous cardiac monitoring in 
the SU may increase the detection of AF. In addition, better 
use of a standardized protocol and quality improvement ac-
tivities in the SU may improve the rate of anticoagulation 
therapy in patients with AF. The aim of this study was to in-
vestigate the effects of SU on the detection of AF that had 
not been recognized at admission and on the use of warfa-
rin therapy in patients with AF.  
MATERIALS AND METHODS
　　　
We included acute cerebral infarction or transient ischemic 
attack (TIA) who had been admitted to the neurology de-
partment within 7 days after symptoms onset. Data were 
analyzed retrospectively using a stroke registry and medical 
records. This study was approved by the Institutional Re-
view Board of Severance Hospital, Yonsei University 
Health System. 
Admission criteria and monitoring in the SU
Admission to the SU required adherence with the written 
admission criteria,8 including stroke within three days after 
symptom onset, recurrent TIA, thrombolytic treatment, pro-
gressive stroke, impending brain herniation, and scheduled 
or performed cerebral digital subtraction angiography or ce-
rebral artery angioplasty/stent. Among them, patients with 
acute cerebral infarction or TIA who had been admitted 
within 7 days after symptoms onset were included.
In all SU patients, electrocardiography (ECG), pulse rate, 
respiration rate, and oxygen saturation were continuously 
monitored. Blood pressure and body temperature were mon-
itored on an hourly basis. Patient neurological status was 
monitored using the National Institute of Health Stroke Scale 
(NIHSS). After stabilization of neurological symptoms, the 
patients were transferred to the general ward (GW) or dis-
charged according to the predetermined discharge criteria 
of the SU.8 
Diagnosis of atrial fibrillation and anticoagulation rate
All patients took standard 12-lead ECG at admission. The 
patient’s previous history of AF and results of the standard 
12-lead ECG at admission were reviewed. During the SU 
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the SU group (83.1%)] (p=0.583).  
Anticoagulation rate
The rate of warfarin therapy was higher in the SU group 
(82.5%) than in the GW group (73.8%) (p=0.019). The rate 
of consideration for anticoagulation was also higher in the 
SU group than in the GW group (Table 2). The most com-
mon reason that stroke survivors did not receive anticoagula-
tion treatment despite consideration was intracerebral hemor-
rhage and large hemorrhagic transformation (Table 3).
DISCUSSION
The benefit of SU care is well-known, and the effects are 
long-lasting.9 However, the precise reason of why SU care 
improves patient outcome is not yet clear.4 In this study, de-
tection of AF and the rate of anticoagulation in stroke pa-
tients with AF increased after the opening of the SU, con-
tributing to improved long-term outcome due to better 
prevention of recurrent strokes.
Although the SU care is one treatment supported by the 
highest level of evidence, models are not uniform among 
hospitals and countries. Common stroke-model compo-
onset. The mean duration of hospitalization was 10.4±9.0 
days in the GW group, and 9.6±9.3 days in the SU group 
(stayed for 4.9±2.5 days in the SU). There was no signifi-
cant difference in the duration of hospitalization between 
the GW group and SU group (p=0.073). 
Hypertension was more common in the SU group than in 
the GW group. Dyslipidemia was more common and the 
baseline NIHSS score was higher in the GW group than in 
the SU group. The remaining demographics, including clas-
sic risk factors for stroke, were not different between the 
groups (Table 1). 
Frequency and detection of atrial fibrillation 
AF was observed in 149 patients (15.7%) in the GW group 
and in 487 patients (20.7%) in the SU group (p=0.001). The 
frequency of AF documented at admission was higher in the 
SU group than in the GW group (Table 2). AF was newly de-
tected during hospitalization in 7 patients (0.7%) in the GW 
group and in 59 patients in the SU group (2.5%, p=0.001) 
(Table 2). 
Most AF detected during admission was paroxysmal AF 
(56 of 66 newly detected AF, 84.8%), and there was no dif-
ference in the types of AF between the two groups [parox-
ysmal AF, 7 of 7 in the GW group (100%) vs. 49 of 59 in 
Table 1. General Patient Characteristics 
GW group (n=951) SU group (n=2349) p value
Gender, male 588 (61.8) 1454 (61.9) 0.971
Mean age, yrs, range 64, 6-91 64, 11-99 0.930
Hypertension 640 (67.3) 1707 (72.7) 0.002
Diabetes mellitus 311 (32.7)   771 (32.8) 0.947
Dyslipidemia 476 (50.1) 1085 (46.2) 0.044
Valvular heart disease 48 (5.0) 101 (4.3) 0.349
Smoking 249 (26.2)   577 (24.6) 0.351
Mean NIHSS score, range 5.8, 0-39 5.2, 0-29 0.043
SU, stroke unit; GW, general ward; NIHSS, National Institutes of Health Stroke Scale.
The numbers in parentheses are percentages. 
Table 2. The Frequencies of Atrial Fibrillation and the Anticoagulation Rates in Patients Who Were Admitted to General Ward 
or Stroke Unit 
GW group (n=951) SU group (n=2349) p value
Atrial fibrillation
    Upon admission 142 (14.9) 428 (18.2) 0.024
    After admission   7 (0.7) 59 (2.5) 0.001
    Total 149 (15.7) 487 (20.7) 0.001
Anticoagulation
    Treatment 110 (73.8) 402 (82.5) 0.019
    Consideration 134 (89.9) 470 (96.5) 0.001
GW, general ward; SU, stroke unit.
The numbers in parentheses are percentages. 
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the increased frequency of AF during ECG monitoring in 
the SU was due to improved detection of paroxysmal AF. 
Although Holter monitoring for 24 hours or for a few days 
may be performed in stroke patients who are not admitted 
to the SU but in the GW, routine implementation of those 
evaluation in stroke patients in the GW is not easy in clini-
cal practice. In this regard, continuous ECG monitoring in 
the SU during acute stage of infarction is more practical. 
Continuous ECG monitoring in the SU may have addition-
al benefits of real time detection of other cardiac disease, 
including acute myocardial infarction as well as AF.
There are several limitations in this study. First, we did 
not use automatic system to detect paroxysmal AF in SU. If 
automatic detect system was available, detection rate of AF 
might be higher than that in this study. Second, the SU group 
included about 78% of acute stroke patients who were ad-
mitted during the study period while the GW group includ-
ed all acute stroke patients. Some of patients who were not 
admitted to the SU were due to presentation to a hospital 
later than 3 days after symptom onset. This might affect the 
results of comparison between the groups, although it might 
be a little. Third, hypertension was more common in the 
SU group. The higher frequency of AF upon admission in 
the SU group may partly be due to the higher frequency of 
hypertension in this group. Nevertheless, our findings dem-
onstrated that detection of AF and the rate of anticoagulant 
use in stroke patients with AF increased after the opening 
of a SU. Stroke-unit care may contribute to improved long-
term outcomes due to better prevention of recurrent stroke 
in patients with AF. Our findings support the benefit of con-
tinuous cardiac monitoring in the SU.
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